DKK1 and rheumatoid arthritis: Since Dkk1 inhibition has further been shown to attenuate erosive bone destruction in a mouse model of rheumatoid arthritis[90], it is highly relevant that Dkk-1 antibodies are under evaluation in clinical studies.